Hydrocephalus Shunts Market: Industry Expert View on Future Growth and Market Trends
Shunt, the surgical insertion of a drainage system is the most common remedy for hydrocephalus. It drains extra cerebrospinal fluid from the brain to another part of the body such as the abdomen, where it can be more easily absorbed. It consists of a long and flexible tube with a valve that keeps fluid from the brain flowing in the right approach and at the proper rate.
Market leaders operating in the market have undertaken various organic growth strategies in the hydrocephalus shunts market. The US hydrocephalus shunts market majorly consists of the players including B. Braun SE, Sophysa SA, Integra LifeSciences Holdings Corp, KANEKA MEDIX CORP, Medtronic Plc; Natus Medical Inc, Anuncia Inc, and Desu Medical among others. The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have utilized organic strategies such as launches, expansion, and product approvals. Moreover, the companies have utilized inorganic strategies including mergers & acquisitions, partnership, and collaborations.
Below is the list of the growth strategies done by the players operating in the US hydrocephalus shunts market:
Jun-2023: Anuncia Medical Inc. announced the successful US commercial launch of the ReFlow Mini Flusher device. Neurosurgeons in the US and soon internationally will now have a new option to reduce the impact of hydrocephalus by providing better access to potentially life-saving therapy for the 30 million patients worldwide suffering from this neurological disorder.
Market leaders operating in the market have undertaken various organic growth strategies in the hydrocephalus shunts market. The US hydrocephalus shunts market majorly consists of the players including B. Braun SE, Sophysa SA, Integra LifeSciences Holdings Corp, KANEKA MEDIX CORP, Medtronic Plc; Natus Medical Inc, Anuncia Inc, and Desu Medical among others. The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have utilized organic strategies such as launches, expansion, and product approvals. Moreover, the companies have utilized inorganic strategies including mergers & acquisitions, partnership, and collaborations.
Below is the list of the growth strategies done by the players operating in the US hydrocephalus shunts market:
Jun-2023: Anuncia Medical Inc. announced the successful US commercial launch of the ReFlow Mini Flusher device. Neurosurgeons in the US and soon internationally will now have a new option to reduce the impact of hydrocephalus by providing better access to potentially life-saving therapy for the 30 million patients worldwide suffering from this neurological disorder.
Comments
Post a Comment